Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

The Health Resources and Services Administration has approved eight manufacturer rebate plans under a new 340B pilot program set to launch Jan. 1. The initiative will replace upfront drug discounts ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

A program that started in the early nineties meant to help low-income patients, is at the forefront. But some worry that ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning whether those savings are being used ...

Most government support programs provide benefits directly to people, whether it is SNAP (Supplemental Nutritional Assistance Program), TANF (Temporary Assistance for Needy Families), or housing ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

Large hospital networks abuse the federal 340B drug discount program that was intended to boost small care providers. | ...